FNCH
Morgan Stanley’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-156
| Closed | -$406 | – | 8093 |
|
|
2024
Q1 | $406 | Sell |
156
-90
| -37% | -$234 | ﹤0.01% | 7257 |
|
|
2023
Q4 | $888 | Buy |
246
+123
| +100% | +$444 | ﹤0.01% | 7218 |
|
|
2023
Q3 | $637 | Hold |
123
| – | – | ﹤0.01% | 7283 |
|
|
2023
Q2 | $1.05K | Sell |
123
-587
| -83% | -$5.01K | ﹤0.01% | 7288 |
|
|
2023
Q1 | $279 | Sell |
710
-94
| -12% | -$37 | ﹤0.01% | 7493 |
|
|
2022
Q4 | $386 | Sell |
804
-19
| -2% | -$9 | ﹤0.01% | 7585 |
|
|
2022
Q3 | $1K | Sell |
823
-26,782
| -97% | -$32.5K | ﹤0.01% | 7649 |
|
|
2022
Q2 | $78K | Buy |
27,605
+1,832
| +7% | +$5.18K | ﹤0.01% | 6400 |
|
|
2022
Q1 | $129K | Sell |
25,773
-1,638
| -6% | -$8.2K | ﹤0.01% | 6164 |
|
|
2021
Q4 | $273K | Buy |
27,411
+8,622
| +46% | +$85.9K | ﹤0.01% | 5894 |
|
|
2021
Q3 | $244K | Buy |
18,789
+17,357
| +1,212% | +$225K | ﹤0.01% | 5893 |
|
|
2021
Q2 | $20K | Buy |
+1,432
| New | +$20K | ﹤0.01% | 7016 |
|